Journal
DIAGNOSTICS
Volume 11, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/diagnostics11040698
Keywords
COVID-19; SARS-CoV-2; ELISA; cytosalivary sampling
Categories
Funding
- Stark S.a.r.l., Monaco
Ask authors/readers for more resources
The global pandemic of COVID-19 has created an unprecedented public health emergency, highlighting the importance of early identification of infected individuals and disruption of transmission pathways. This study aims to provide a rapid and sensitive method for diagnosing SARS-CoV-2 infection, with the goal of reducing the spread of the virus.
The coronavirus disease 2019 (COVID-19) global pandemic created an unprecedented public health emergency. Early recognition of an infected person and disruption of the transmission pathway are the keys to controlling this major public health threat around the world. The scientifically reliable screening method is an RT-PCR test that is performed on an ororhinopharyngeal swab in the laboratory. In the current severe SARS-CoV-2 pandemic, it is necessary to identify devices for rapid diagnosis to reduce the spread of the disease. The aim of this study was to provide a qualitative, rapid, sensitive, and specific method for a diagnosis of SARS-CoV-2 infection based on the recognition of specific antigens of the SARS-CoV-2 virus. The device was built by assembling commercially available and custom-made semi-finished products. The method was performed in environments outside the laboratory, i.e., patient side, with an immediate chemocolorimetric response or with a digital reader using an ELISA method.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available